Medline Industries India Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
- Paid Up Capital ₹ 0.10 M
- Company Age 14 Year, 11 Months
- Last Filing with ROC 31 Mar 2023
- Revenue Growth 35.29%
- Profit Growth 36.11%
- Ebitda 27.02%
- Net Worth 39.18%
- Total Assets 25.74%
About Medline Industries India
Medline Industries India Private Limited (MIIPL) is a leading Private Limited Foreign Company Incorporated In India incorporated in India on 17 February 2010 and has a history of 14 years and 11 months. Its registered office is in Pune, Maharashtra, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Atul Devasthali, Ramakrishnan Thiagarajan, and Michael Drazin serve as directors at the Company.
Company Details
-
Location
Pune, Maharashtra, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media
Corporate Identity Details
-
CIN/LLPIN
U74999PN2010FTC135611
-
Company No.
135611
-
Company Classification
Private Limited Foreign Company Incorporated In India
-
Incorporation Date
17 Feb 2010
-
Date of AGM
27 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Pune
Industry
Who are the key members and board of directors at Medline Industries India?
Board Members (3)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Atul Devasthali | Director | 17-Feb-2010 | Current |
Ramakrishnan Thiagarajan | Director | 03-Jul-2017 | Current |
Michael Drazin | Director | 21-Nov-2018 | Current |
Financial Performance of Medline Industries India.
Medline Industries India Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 35.29% increase. The company also saw a substantial improvement in profitability, with a 36.11% increase in profit. The company's net worth Soared by an impressive increase of 39.18%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
|
||||||
Revenue from Operations |
|
||||||
Total Assets |
|
||||||
Profit or Loss |
|
||||||
Net Worth |
|
||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Medline Industries India?
In 2022, Medline Industries India had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Medline Industries India?
Medline Industries India has a workforce of 1305 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Medline Industries India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Medline Industries India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.